Development of first-generation research equipment (incubators, shaker incubators, centrifuges, etc.).

Global expansion from South Korea.

Venture company certification and commendation by the Prime Minister of Korea.

Construction of stem cell GMP facilities in China and Japan.

Development of stem cell separation medical devices (FDA, CE, KFDA approved).

ISSCA conferences held in Morocco, Turkey, Mongolia, and Malaysia

Automation of stem cell processes.

Establishment of offices in Hong Kong and Vietnam

Formation of the International Regenerative Medicine Association (IRMA).

Expansion into the Middle East (Saudi Arabia, Dubai, Qatar, Kuwait).

Establishment of pharmaceutical and research institutes in Beijing, China with a capital investment of $200 million.

Scheduled to establish pharmaceutical research institutes in the Middle East (Qatar, Dubai, Saudi Arabia) and Japan.